173 related articles for article (PubMed ID: 2473136)
21. Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factor.
Reiss M; Sartorelli AC
Cancer Res; 1987 Dec; 47(24 Pt 1):6705-9. PubMed ID: 2445478
[TBL] [Abstract][Full Text] [Related]
22. BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines.
Weissman BE; Aaronson SA
Cell; 1983 Feb; 32(2):599-606. PubMed ID: 6297803
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor activates phosphoinositide turnover and protein kinase C in BALB/MK keratinocytes.
Moscat J; Molloy CJ; Fleming TP; Aaronson SA
Mol Endocrinol; 1988 Sep; 2(9):799-805. PubMed ID: 2459606
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor beta 1, and triiodothyronine in MDA-468 cells.
Fernandez-Pol JA; Hamilton PD; Klos DJ
J Biol Chem; 1989 Mar; 264(7):4151-6. PubMed ID: 2563727
[TBL] [Abstract][Full Text] [Related]
25. Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes.
Falco JP; Taylor WG; Di Fiore PP; Weissman BE; Aaronson SA
Oncogene; 1988 Jun; 2(6):573-8. PubMed ID: 3290805
[TBL] [Abstract][Full Text] [Related]
26. The calcium signal for Balb/MK keratinocyte terminal differentiation induces sustained alterations in phosphoinositide metabolism without detectable protein kinase C activation.
Moscat J; Fleming TP; Molloy CJ; Lopez-Barahona M; Aaronson SA
J Biol Chem; 1989 Jul; 264(19):11228-35. PubMed ID: 2472392
[TBL] [Abstract][Full Text] [Related]
27. Proliferation and differentiation of human squamous carcinoma cell lines and normal keratinocytes: effects of epidermal growth factor, retinoids, and hydrocortisone.
Ponec M; Weerheim A; Kempenaar J; Boonstra J
In Vitro Cell Dev Biol; 1988 Aug; 24(8):764-70. PubMed ID: 2457573
[TBL] [Abstract][Full Text] [Related]
28. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
[TBL] [Abstract][Full Text] [Related]
29. Suppression of the EGF-dependent induction of c-myc proto-oncogene expression by transforming growth factor beta in a human breast carcinoma cell line.
Fernandez-Pol JA; Talkad VD; Klos DJ; Hamilton PD
Biochem Biophys Res Commun; 1987 May; 144(3):1197-205. PubMed ID: 3495272
[TBL] [Abstract][Full Text] [Related]
30. Effects of prostaglandins and hydroxyoctadecadienoic acid on epidermal growth factor-dependent DNA synthesis and c-myc proto-oncogene expression in Syrian hamster embryo cells.
Cowlen MS; Eling TE
Biochim Biophys Acta; 1993 Sep; 1174(3):234-40. PubMed ID: 8373802
[TBL] [Abstract][Full Text] [Related]
31. Cellular analysis of the kinetics of alpha-fetoprotein and nuclear oncogene activation in primary cultures of adult rat hepatocytes stimulated by epidermal growth factor.
Tournier-Thurneyssen I; Feldmann G; Bernuau D
Biol Cell; 1992; 75(1):61-8. PubMed ID: 1381255
[TBL] [Abstract][Full Text] [Related]
32. EGF receptor activity and mitogenic response of Balb/3T3 cells expressing Ras and Myc oncogenes. EGF receptor activity in oncogene transformed cells.
Gopas J; Ono M; Princler G; Smith MR; Tainsky MA; Siddiqui MA; Wishniak O; Segal S; Kuwano M; Kung HF
Cell Mol Biol; 1992 Sep; 38(6):605-14. PubMed ID: 1303308
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the ability of basic and acidic fibroblast growth factor to stimulate the proliferation of an established keratinocyte cell line: modulation of their biological effects by heparin, transforming growth factor beta (TGF beta), and epidermal growth factor (EGF).
Gospodarowicz D; Plouët J; Malerstein B
J Cell Physiol; 1990 Feb; 142(2):325-33. PubMed ID: 2303528
[TBL] [Abstract][Full Text] [Related]
34. Isolation and characterization of Kirsten murine sarcoma virus-transformed mouse keratinocytes resistant to transforming growth factor beta.
Sipes NJ; Lyons RM; Moses HL
Mol Carcinog; 1990; 3(1):12-9. PubMed ID: 2157456
[TBL] [Abstract][Full Text] [Related]
35. Trans retinoic acid enhances the growth response of epidermal keratinocytes to epidermal growth factor and transforming growth factor beta.
Tong PS; Horowitz NN; Wheeler LA
J Invest Dermatol; 1990 Jan; 94(1):126-31. PubMed ID: 2295827
[TBL] [Abstract][Full Text] [Related]
36. Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells.
Ono M; Nakayama Y; Princler G; Gopas J; Kung HF; Kuwano M
Exp Cell Res; 1992 Dec; 203(2):456-65. PubMed ID: 1459205
[TBL] [Abstract][Full Text] [Related]
37. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
[TBL] [Abstract][Full Text] [Related]
38. Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-beta.
Zendegui JG; Inman WH; Carpenter G
J Cell Physiol; 1988 Aug; 136(2):257-65. PubMed ID: 2457593
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells.
Satterwhite DJ; Aakre ME; Gorska AE; Moses HL
Cell Growth Differ; 1994 Aug; 5(8):789-99. PubMed ID: 7986745
[TBL] [Abstract][Full Text] [Related]
40. Induction of c-fos and c-myc mRNA by epidermal growth factor or calcium ionophore is cAMP dependent.
Ran W; Dean M; Levine RA; Henkle C; Campisi J
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8216-20. PubMed ID: 2430281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
